| Recognition of bacterial infection by innate immune sensors S Kumar, H Ingle, DVR Prasad, H Kumar Critical reviews in microbiology 39 (3), 229-246, 2013 | 243 | 2013 |
| Combining PARP with ATR inhibition overcomes PARP inhibitor and platinum resistance in ovarian cancer models H Kim, H Xu, E George, D Hallberg, S Kumar, V Jagannathan, ... Nature communications 11 (1), 3726, 2020 | 211 | 2020 |
| Notch ligand Dll1 mediates cross-talk between mammary stem cells and the macrophageal niche R Chakrabarti, T Celià-Terrassa, S Kumar, X Hang, Y Wei, A Choudhury, ... Science 360 (6396), eaan4153, 2018 | 175 | 2018 |
| The microRNA miR-485 targets host and influenza virus transcripts to regulate antiviral immunity and restrict viral replication H Ingle, S Kumar, AA Raut, A Mishra, DD Kulkarni, T Kameyama, ... Science signaling 8 (406), ra126-ra126, 2015 | 163 | 2015 |
| ΔNp63-driven recruitment of myeloid-derived suppressor cells promotes metastasis in triple-negative breast cancer S Kumar, DW Wilkes, N Samuel, MA Blanco, A Nayak, K Alicea-Torres, ... The Journal of Clinical Investigation 128 (11), 5095-5109, 2018 | 121 | 2018 |
| Loss of ELF5–FBXW7 stabilizes IFNGR1 to promote the growth and metastasis of triple-negative breast cancer through interferon-γ signalling S Singh, S Kumar, RK Srivastava, A Nandi, G Thacker, H Murali, S Kim, ... Nature cell biology 22 (5), 591-602, 2020 | 77 | 2020 |
| Estrogen-dependent DLL1-mediated Notch signaling promotes luminal breast cancer S Kumar, RK Srivastav, DW Wilkes, T Ross, S Kim, J Kowalski, S Chatla, ... Oncogene 38 (12), 2092-2107, 2019 | 73 | 2019 |
| IPS-1 differentially induces TRAIL, BCL2, BIRC3 and PRKCE in type I interferons-dependent and-independent anticancer activity S Kumar, H Ingle, S Mishra, RS Mahla, A Kumar, T Kawai, S Akira, ... Cell death & disease 6 (5), e1758-e1758, 2015 | 71 | 2015 |
| The role of TLR9 polymorphism in susceptibility to pulmonary tuberculosis D Bharti, A Kumar, RS Mahla, S Kumar, H Ingle, H Shankar, B Joshi, ... Immunogenetics 66, 675-681, 2014 | 63 | 2014 |
| Tumor glycolysis, an essential sweet tooth of tumor cells S Paul, S Ghosh, S Kumar Seminars in cancer biology 86, 1216-1230, 2022 | 54 | 2022 |
| Dll1+ quiescent tumor stem cells drive chemoresistance in breast cancer through NF-κB survival pathway S Kumar, A Nandi, S Singh, R Regulapati, N Li, JW Tobias, CW Siebel, ... Nature communications 12 (1), 432, 2021 | 50 | 2021 |
| MicroRNA hsa-miR-324-5p suppresses H5N1 virus replication by targeting the viral PB1 and host CUEDC2 A Kumar, A Kumar, H Ingle, S Kumar, R Mishra, MK Verma, D Biswas, ... Journal of virology 92 (19), 10.1128/jvi. 01057-18, 2018 | 48 | 2018 |
| Low prevalence of CCR5-Δ32, CCR2-64I and SDF1-3′A alleles in the Baiga and Gond tribes of Central India D Bharti, A Kumar, RS Mahla, S Kumar, H Ingle, T Yadav, A Mishra, ... SpringerPlus 4, 1-5, 2015 | 11 | 2015 |
| Inducible knockout of∆ Np63 alters cell polarity and metabolism during pubertal mammary gland development S Kumar, A Nandi, A Mahesh, S Sinha, E Flores, R Chakrabarti FEBS letters 594 (6), 973-985, 2020 | 9 | 2020 |
| Estrogen receptor β-mediated inhibition of actin-based cell migration suppresses metastasis of inflammatory breast cancer C Thomas, IV Karagounis, RK Srivastava, N Vrettos, F Nikolos, N Francois, ... Cancer research 81 (9), 2399-2414, 2021 | 6 | 2021 |
| A B7-H4–Targeting Antibody–Drug Conjugate Shows Antitumor Activity in PARPi and Platinum-Resistant Cancers with B7-H4 Expression SB Gitto, M Whicker, G Davies, S Kumar, K Kinneer, H Xu, A Lewis, ... Clinical Cancer Research 30 (8), 1567-1581, 2024 | 1 | 2024 |
Harshad IngleCenter for Genome Sciences and Systems Biology, Washington University School of MedicineVerified email at wustl.edu
